Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Geriatric Depression Scale (Long Form)
1
x
$
0.00
Psychopharmacology Bulletin VOL 37 Supplement No. 2 - Full Issue Stacked PDF
1
x
$
60.00
Generalized Anxiety Disorder: Raising the Expectations of Treatment
1
x
$
30.00
Hyperprolactinemia, Clinical Considerations, and Infertility in Women on Antipsychotic Medications
1
x
$
30.00
The History of Valproate in Clinical Neuroscience
1
x
$
30.00
Rating Scales and Safety Measurements in Bipolar Disorder and Schizophrenia – A Reference Guide
1
x
$
0.00
Psychopharmacology Bulletin VOL 47 No. 1, 2017 - Full Issue Stacked PDF
1
x
$
60.00
Divalproex in the Treatment of Migraine
1
x
$
30.00
View Cart
Checkout
Home
schizophrenia
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Psychopharmacology Bulletin VOL 47 No. 2, 2017 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
$
0.00
Add to cart
Details
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
$
0.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
$
0.00
Add to cart
Details
Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil
$
0.00
Add to cart
Details
A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil
$
0.00
Add to cart
Details
Psychopharmacology Bulletin VOL 47 No. 3, 2017 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Physical Activity Diminishes Symptomatic Decline in Chronic Schizophrenia: A Systematic Review
$
30.00
Add to cart
Details
Rating Scales and Safety Measurements in Bipolar Disorder and Schizophrenia – A Reference Guide
$
0.00
Add to cart
Details
Successful Management of Psychotropics Induced Stuttering Priapism with Pseudoephedrine in a Patient with Schizophrenia
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 48 No. 2, 2018 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Exercise as a Treatment for Schizophrenia: A Review
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 49 No. 1, 2019 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Oral Antipsychotic Versus Long- Acting Injections Antipsychotic in Schizophrenia Spectrum Disorder: a Mirror Analysis in a Real-World Clinical Setting
$
30.00
Add to cart
Details
Serum Concentration of Paliperidone Palmitate Administered Every 3 Weeks
$
30.00
Add to cart
Details
Involuntary Facial Twitching in a Patient with Schizophrenia on Treatment with Long Acting Injectable Olanzapine
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 49 No. 2, 2019 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Lumateperone for the Treatment of Schizophrenia
$
30.00
Add to cart
Details
Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults
$
30.00
Add to cart
Details
Brexpiprazole for the Treatment of Schizophrenia and Major Depressive Disorder: A Comprehensive Review of Pharmacological Considerations in Clinical Practice
$
30.00
Add to cart
Details
Previous
1
2
3
4
Next
Page load link
Go to Top
